PROVIDER PROFILE · NPI 1578716262

Monika DattD.O.

PRACTICETHEOFANIS MITSINIKOS, DO, PCSee all providers at this practice →

EndocrinologyStony Brook, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,584

Unique beneficiaries

—

Total services

2,638

Distinct HCPCS

Medicare payment

$125K

Peer benchmark

Total Medicare services vs. 627 Endocrinology providers in NY — top quintile (cohort median 837).

PRESCRIBING · PART D · 2024

Total Rx claims

3,008

Beneficiaries

—

Total drug cost

$1.5M

Distinct drugs

Brand share

52.3%

Top prescribed drugs

Levothyroxine Sodium402 claims

Metformin Hcl207 claims

Semaglutide205 claims

Metformin Hcl139 claims

Glimepiride138 claims

QUALITY · MIPS · 2024

Final MIPS score

99.2

Quality

35.0

Cost

64.8

Improvement activities

40.0

Promoting interop.

99.0

Payment adjustment

1.02%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Monika Datt's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Theofanis Mitsinikos Endocrinology · Stony Brook, NY	68	179
Sunrise Medical Laboratories, Inc. Clinical Laboratory · Hicksville, NY	35	71
JOHN T. MATHER MEMORIAL HOSPITAL	27	62
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Melville, NY	19	60
ST. CHARLES HOSPITAL	11	15

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history